Skip to main content
Top
Published in: Child's Nervous System 5/2019

01-05-2019 | Case Report

Surgical consideration in Hunter syndrome: a case of hydrocephalus and a case of epidural hematoma

Authors: Jin Li, Xinyan Zhang, Raynald, Tao Jiang, Chunde Li

Published in: Child's Nervous System | Issue 5/2019

Login to get access

Abstract

Introduction

Hunter syndrome (HS) is a rare X-linked lysosomal storage disorder which affects multiple organ systems. Surgical intervention and general anesthesia should be used with caution because of significant airway complications.

Case report

Two HS patients underwent surgery with different prognosis are presented below. In the first case, symptoms of progressive disabilities on motor function, language, intelligence, and development last for 1 year in a 6-year-old boy; magnetic resonance imaging (MRI) showed severe hydrocephalus. Third ventriculostomy was performed in this patient to relieve the hydrocephalus. Unfortunately, this patient died postoperatively due to postsurgical tracheal collapse. In the second case, an 8-year-old girl was referred to our hospital with epidural hematoma because of a falling accident. Trephination surgery was performed under local anesthesia to remove the hematoma. Three days postsurgical, the patient was discharged uneventfully.

Conclusion

General anesthesia in HS patients was associated with poor prognosis due to respiratory complications. Local anesthesia and less intensified treatment should be recommended.
Literature
1.
go back to reference Neufeld EU, Muenzer J (2001) The mucopolysaccharidoses. In: The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452 Neufeld EU, Muenzer J (2001) The mucopolysaccharidoses. In: The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452
2.
go back to reference Gupta R, Pandey CB, Tripathi S (2014) Mucopolysaccharidosis type II (Hunter’s syndrome) - a clinical case report. Journal of Indian College of Cardiology 5:61–66 Gupta R, Pandey CB, Tripathi S (2014) Mucopolysaccharidosis type II (Hunter’s syndrome) - a clinical case report. Journal of Indian College of Cardiology 5:61–66
3.
go back to reference Ballabio A, Gieselmann V (2009) Lysosomal disorders: from storage to cellular damage. Biochim Biophys Acta 1793:684–696CrossRefPubMed Ballabio A, Gieselmann V (2009) Lysosomal disorders: from storage to cellular damage. Biochim Biophys Acta 1793:684–696CrossRefPubMed
4.
go back to reference Scarpa M (2007) Mucopolysaccharidosis Type II. In: R.A. Pagon, T.D. Bird, C.R. Dolan, et al. (eds) GeneReviewsTM [Internet]. (Seattle (WA), USA) Scarpa M (2007) Mucopolysaccharidosis Type II. In: R.A. Pagon, T.D. Bird, C.R. Dolan, et al. (eds) GeneReviewsTM [Internet]. (Seattle (WA), USA)
5.
go back to reference Jones SA, Almassy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami R, Tincheva T, Wraith JE, investigators H (2009) Mortality and cause of death in mucopolysaccharidosis type II - a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis 32:534–543CrossRefPubMed Jones SA, Almassy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami R, Tincheva T, Wraith JE, investigators H (2009) Mortality and cause of death in mucopolysaccharidosis type II - a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis 32:534–543CrossRefPubMed
6.
go back to reference Schwartz GP, Cohen EJ (1998) Hydrocephalus in Maroteaux-Lamy syndrome. Arch Ophthalmol 116:400PubMed Schwartz GP, Cohen EJ (1998) Hydrocephalus in Maroteaux-Lamy syndrome. Arch Ophthalmol 116:400PubMed
7.
go back to reference Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, van Velthoven V (2001) Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 35:35–38CrossRefPubMed Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, van Velthoven V (2001) Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 35:35–38CrossRefPubMed
8.
go back to reference Aliabadi H, Reynolds R, Powers CJ, Grant G, Fuchs H, Kurtzberg J (2010) Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients. Neurosurgery 67:1476–1481 discussion 1481–1472CrossRefPubMed Aliabadi H, Reynolds R, Powers CJ, Grant G, Fuchs H, Kurtzberg J (2010) Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients. Neurosurgery 67:1476–1481 discussion 1481–1472CrossRefPubMed
9.
go back to reference Kawaguchi T, Fujimura M, Tominaga T (2009) Syringomyelia with obstructive hydrocephalus at the foramens of Luschka and Magendie successfully treated by endoscopic third ventriculostomy. Surg Neurol 71:349–352 discussion 352CrossRefPubMed Kawaguchi T, Fujimura M, Tominaga T (2009) Syringomyelia with obstructive hydrocephalus at the foramens of Luschka and Magendie successfully treated by endoscopic third ventriculostomy. Surg Neurol 71:349–352 discussion 352CrossRefPubMed
10.
go back to reference Neto AR, Holanda GB, Farias MC, Santos da Costa G, Pereira HS (2013) Hydrocephalus in mucopolysaccharidosis type VI successfully treated with endoscopic third ventriculostomy. J Neurosurg Pediatr 11:327–330CrossRefPubMed Neto AR, Holanda GB, Farias MC, Santos da Costa G, Pereira HS (2013) Hydrocephalus in mucopolysaccharidosis type VI successfully treated with endoscopic third ventriculostomy. J Neurosurg Pediatr 11:327–330CrossRefPubMed
11.
go back to reference Morehead JM, Parsons DS (1993) Tracheobronchomalacia in Hunter's syndrome. Int J Pediatr Otorhinolaryngol 26:255–261CrossRefPubMed Morehead JM, Parsons DS (1993) Tracheobronchomalacia in Hunter's syndrome. Int J Pediatr Otorhinolaryngol 26:255–261CrossRefPubMed
12.
go back to reference Nagano R, Takizawa S, Hayama N, Umemura S, Uesugi T, Nakagawa S, Okamoto S, Yanagimachi N, Takagi S (2007) Three-dimensional ct and histopathological findings of airway malacia in hunter syndrome. Tokai J Exp Clin Med 32:59–61PubMed Nagano R, Takizawa S, Hayama N, Umemura S, Uesugi T, Nakagawa S, Okamoto S, Yanagimachi N, Takagi S (2007) Three-dimensional ct and histopathological findings of airway malacia in hunter syndrome. Tokai J Exp Clin Med 32:59–61PubMed
13.
go back to reference Muhlebach MS, Wooten W, Muenzer J (2011) Respiratory manifestations in mucopolysaccharidoses. Paediatr Respir Rev 12:133–138CrossRefPubMed Muhlebach MS, Wooten W, Muenzer J (2011) Respiratory manifestations in mucopolysaccharidoses. Paediatr Respir Rev 12:133–138CrossRefPubMed
14.
go back to reference Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga AC, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A (2006) A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (hunter syndrome). Genet Med 8:465–473CrossRefPubMed Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga AC, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A (2006) A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (hunter syndrome). Genet Med 8:465–473CrossRefPubMed
15.
go back to reference Muenzer J, Beck M, Eng C, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E (2009) Multidisciplinary management of Hunter syndrome. Pediatrics 124:1228–1239CrossRef Muenzer J, Beck M, Eng C, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E (2009) Multidisciplinary management of Hunter syndrome. Pediatrics 124:1228–1239CrossRef
16.
go back to reference Okuyama T, Tanaka A, Suzuki Y, Ida H, Tanaka T, Cox GF, Eto Y, Orii T (2010) Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II). Mol Genet Metab 99:18–25CrossRefPubMed Okuyama T, Tanaka A, Suzuki Y, Ida H, Tanaka T, Cox GF, Eto Y, Orii T (2010) Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II). Mol Genet Metab 99:18–25CrossRefPubMed
17.
go back to reference Parini R, Rigoldi M, Tedesco L, Boffi L, Brambilla A, Bertoletti S, Boncimino A, Del Longo A, De Lorenzo P, Gaini R, Gallone D, Gasperini S, Giussani C, Grimaldi M, Grioni D, Meregalli P, Messinesi G, Nichelli F, Romagnoli M, Russo P, Sganzerla E, Valsecchi G, Biondi A (2015) Enzymatic replacement therapy for hunter disease: up to 9 years experience with 17 patients. Mol Genet Metab Rep 3:65–74CrossRefPubMedPubMedCentral Parini R, Rigoldi M, Tedesco L, Boffi L, Brambilla A, Bertoletti S, Boncimino A, Del Longo A, De Lorenzo P, Gaini R, Gallone D, Gasperini S, Giussani C, Grimaldi M, Grioni D, Meregalli P, Messinesi G, Nichelli F, Romagnoli M, Russo P, Sganzerla E, Valsecchi G, Biondi A (2015) Enzymatic replacement therapy for hunter disease: up to 9 years experience with 17 patients. Mol Genet Metab Rep 3:65–74CrossRefPubMedPubMedCentral
18.
go back to reference Mendelsohn NJ, Harmatz P, Bodaner O, Burton BK, Giugliani R, Jones SA, Lampe C, Malm G, Steiner RD, Parini R, Investigators HOS (2010) Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genet Med 12:816–822CrossRefPubMed Mendelsohn NJ, Harmatz P, Bodaner O, Burton BK, Giugliani R, Jones SA, Lampe C, Malm G, Steiner RD, Parini R, Investigators HOS (2010) Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genet Med 12:816–822CrossRefPubMed
19.
go back to reference Quong WL, Kanani M, Elliott MJ (2015) Aorto-Tracheopexy in the treatment of Hunter Syndrome. Ann Thorac Surg 99:2190–2192CrossRefPubMed Quong WL, Kanani M, Elliott MJ (2015) Aorto-Tracheopexy in the treatment of Hunter Syndrome. Ann Thorac Surg 99:2190–2192CrossRefPubMed
20.
go back to reference Kamin W (2008) Diagnosis and management of respiratory involvement in hunter syndrome. Acta Paediatr 97:57–60CrossRefPubMed Kamin W (2008) Diagnosis and management of respiratory involvement in hunter syndrome. Acta Paediatr 97:57–60CrossRefPubMed
Metadata
Title
Surgical consideration in Hunter syndrome: a case of hydrocephalus and a case of epidural hematoma
Authors
Jin Li
Xinyan Zhang
Raynald
Tao Jiang
Chunde Li
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 5/2019
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-018-3998-0

Other articles of this Issue 5/2019

Child's Nervous System 5/2019 Go to the issue